GL1X · GenesisL1 explorer

MolNFT v1 · #118665 · protein

The crystal structure of human plasma kallikrein in complex with its peptide inhibitor pkalin-1

5F8Z · Plasma kallikrein light chain: “The crystal structure of human plasma kallikrein in complex with its peptide inhibitor pkalin-1”. X-ray diffraction, 2 ligands (MRZ, SO4), 1 pocket (best druggability 0.51). MolNFT v1 #118665 on…

PDB
5F8Z
Type
protein
Length
249 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Plasma kallikrein light chain; Cys-pro-ala-arg-phe-M70-ala-leu-phe-cys
EC
3.4.21.34
UniProt
P03952
Ligands
MRZ, SO4
Pockets
1 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APlasma kallikrein light chain (EC 3.4.21.34)protein23913% helix, 35% strandP03952
BCys-pro-ala-arg-phe-M70-ala-leu-phe-cysprotein100% helix, 10% strand—

Ligands and binding sites

  • MRZ · piperidine-1-carboximidamide · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1600.510.8722MRZ

Interfaces

1 interface between chains.

  • A–B · 640 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 5F8Z · The crystal structure of human Plasma Kallikrein in complex with its peptide inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • P03952 · AlphaFold monomer V2.0 prediction for plasma kallikrein (P03952) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.